Hepatic TLR signaling is activated in NAFLD, and TLR2, TLR4, TLR5, TLR9 are all implicated in the pathogenesis of NAFLD. The gene discussed is TLR2; the disease is metabolic dysfunction-associated steatotic liver disease.